A recent study by Jia and colleagues have reported that the PXN-AS1-L-induced increased expression of SAPCD2 by disrupting the binding of the microRNAs-mediated silencing complex to SAPCD2 predicted a worse prognosis in nasopharyngeal carcinoma patients (15). This evidence concerns the gene SAPCD2 and nasopharyngeal carcinoma.